Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 228 citing Boumpas: Systemic Lupus Erythematosus: Emerging Concepts: Part 1: Renal, Neuropsychiatric,.... (0.10 sec) 

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in …


JM Esdaile, M Abrahamowicz, T Grodzicky, Y Li, … - Arthritis Care & Research - interscience.wiley.com
The participants at two SLE registries were assessed retrospectively for the
baseline level of the Framingham study risk factors and for the presence of
vascular outcomes: nonfatal myocardial infarction (MI), death due to CHD, ...
Cited by 353 - Related articles - BL Direct - All 4 versions

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

- shouxi.net
EM Ginzler, MA Dooley, C Aranow, MY Kim, J … - The New England journal of medicine, 2005 - nejm.highwire.org
Methods We conducted a 24-week randomized, open-label, noninferiority trial
comparing oral mycophenolate mofetil (initial dose, 1000 mg per day, increased
to 3000 mg per day) with monthly intravenous cyclophosphamide (0.5 g per ...
Cited by 308 - Related articles - BL Direct - All 9 versions

Mycophenolate Mofetil Therapy in Lupus Nephritis: ClinicalObservations

- asnjournals.org
MA Dooley, FG Cosio, PH Nachman, ME … - Journal of the American Society of Nephrology, 1999 - Am Soc Nephrol
Abstract. Controlled clinical trials in renal transplantation have demonstrated
that mycophenolate mofetil is well tolerated and has lower renal transplant
rejection rates than azathioprine regimens. This study reports on the ...
Cited by 199 - Related articles - BL Direct - All 6 versions

A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and …


DT Boumpas, R Furie, S Manzi, GG Illei, DJ … - Arthritis and rheumatism, 2003 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 176 - Related articles - BL Direct - All 4 versions

Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis


S Kim, SM Liva, MA Dalal, MA Verity, RR … - Neurology, 1999 - AAN Enterprises
From the Departments of Neurology (S. Kim, SM Liva, MA Dalal, and Dr. Voskuhl)
and Pathology and Laboratory Medicine/Neuropathology (Dr. Verity), University of
California Los Angeles School of Medicine, CA. ... Address correspondence ...
Cited by 165 - Related articles - All 6 versions

Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans


MA Dooley, S Hogan, C Jennette, R Falk, … - Kidney international, 1997 - nature.com
Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black
Americans. Intravenous cyclophosphamide is widely used to treat severe lupus
nephritis. Yet interpretation of the literature is limited by the small ...
Cited by 164 - Related articles - BL Direct - All 3 versions

Lupus nephritis


JHM Berden - Kidney international, 1997 - nature.com
Kidney International aims to inform the renal researcher and practicing nephrologists
on all aspects of renal research. Clinical and basic renal research, commentaries ...
Cited by 144 - Related articles - BL Direct - All 4 versions

Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation …

- jimmunol.org
SL Kalled, AH Cutler, SK Datta, DW Thomas - The Journal of Immunology, 1998 - Am Assoc Immnol
Prior studies have demonstrated that treatment of young, prenephritic
lupus-prone mice with Ab directed against CD40 ligand (CD40L) prolongs survival
and decreases the incidence of severe nephritis. In this report, we show ...
Cited by 133 - Related articles - BL Direct - All 3 versions

Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension

- 171.66.122.149
HH Leuchte, C Neurohr, R Baumgartner, M … - American journal of respiratory and critical care …, 2004 - 171.66.122.149
Pulmonary hypertension (PH) can develop in lung fibrosis, and contributes to
increased morbidity and mortality. Noninvasive parameters in the evaluation of
PH in lung disease could aid in the management of these subjects. In this ...
Cited by 126 - Related articles - BL Direct - All 7 versions

Corticosteroids in acute respiratory failure


MA Jantz, SA Sahn - American journal of respiratory and critical care …, 1999 - 171.66.122.149
Corticosteroids have been advocated for a host of conditions which the
pulmonologist/intensivist may encounter as causes of acute respiratory failure.
The purpose of this article is to examine the data and rationale for use of ...
Cited by 110 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google